Effect of Clot Aging and Cholesterol Content on Ultrasound-Assisted Thrombolysis

Translational Stroke Research

Volumn 5, Issue 5, 2014, Pages 627-634

  Zhou, Yufeng ^a   Murugappan, Suresh Kanna ^a   Sharma, Vijay Kumar ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cholesterol; Clot aging; Sonothrombolysis; Stroke

Indexed keywords

CHOLESTEROL; FIBRIN; PHOSPHATE BUFFERED SALINE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

AGING; ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD RHEOLOGY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ERYTHROCYTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEAR STRENGTH; SONOTHROMBOLYSIS; ULTRASOUND ASSISTED THROMBOLYSIS; WEIGHT REDUCTION; ANIMAL; BLOOD; FIBRINOLYTIC THERAPY; HORSE; MULTIMODALITY CANCER THERAPY; STROKE; TIME; ULTRASOUND THERAPY;

ANIMALS; BLOOD COAGULATION; CHOLESTEROL; COMBINED MODALITY THERAPY; FIBRINOLYTIC AGENTS; HORSES; HUMANS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONIC THERAPY;

EID: 84905579766     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0332-3     Document Type: Article

References (39)

1. World Health Organization. Fact sheet: The top ten causes of death. 2011. http://www. who. int. Accessed 25 July 2013.
2. Wadey AL, Muyderman HC, Kwek PT, Sims NR. Mitochondrial glutathione uptake: characterization in isolated brain mitochondria and astrocytes in culture. J Neurochem. 2009;109: 101-8.
3. Ferry JD, Miller M, Shulman S. The conversion of fibrinogen to fibrin. VII. Rigidity and stress relaxation of fibrin clots; effects of calcium. Arch Biochem Biophys. 1951;34: 424-36.
4. Pai SB, Varman RG, Kulkarni RN. Microsurgical anatomy of middle cerebral artery. Neurol India. 2005;53(2): 186-90.
5. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333: 1581-7.
6. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375: 1695-703.
7. Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. 2003;2(5): 283-90.
8. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351: 2170-8.
9. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 2010;41: 280-7.
10. Holland CK, Vaidya SS, Datta S, Coussios C-C, Shaw GJ. Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model. Thromb Res. 2008;121: 663-73.
11. Shaw GJ, Bavani N, Dhamija A, Lindsell CJ. Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model. Thromb Res. 2006;117: 603-8.
12. Ueshima S, Matsuo O. The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians. Thromb Haemost. 2002;87: 544-6.
13. Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Koike K, et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb Vasc Biol. 1993;13: 783-90.
14. Stewart BB, Krut LH. The interdependence of prospective and retrospective studies in research on ischaemic heart disease. J Atheroscler Res. 1962;2: 317-31.
15. Eliot RS, Kanjuh VI, Edwards JE. Atheromatous embolism. Circulation. 1964;30: 611-8.
16. Glew HR, Okolie H, Huang YS, Chuang LT, Suberu O, Crossey M, et al. Abnormalities in the fatty-acid composition of the serum phospholipids of stroke patients. J Natl Med Assoc. 2004;96(6): 826-32.
17. Evans PA, Hawkins K, Williams PR. Rheometry for blood coagulation studies. Rheology Reviews. 2006: 255-91.
18. Riha P, Wang X, Liao R, Stoltz JF. Elasticity and fracture strain of whole blood clots. Clin Hemorheol Microcirc. 1999;21(1): 45-9.
19. Savushkinl AV. Tensile strength of native blood clots. J Thromb Haemost. 2007;5: 2.
20. Eggers J, Ossadnik S, Seidel G. Enhanced clot dissolution in vitro by 1. 8-MHz pulsed ultrasound. Ultrasound Med Biol. 2009;35(3): 523-36.
21. Siegel RJ, Luo H. Ultrasound thrombolysis. Ultrasonics. 2008;48(4): 312-20.
22. Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med. 2000;343(10): 710-22.
23. Poungvarin N. Stroke in the developing world. Lancet. 1998;352(Sppl. III): SIII19-22.
24. Minematsu K, Yamaguchi T, Omae T. Spectacular shrinking deficit: rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology. 1992;42: 157-62.
25. Minnerup J, Kleinschnitz C. Visualization of clot composition in ischemic stroke, do we get what we see? Stroke. 2011;42: 1193-4.
26. Weisel JW. The mechanical properties of fibrin for basic scientist and clinicians. Biophys Chem. 2004;112: 267-76.
27. Zabczyk M, Hondo L, Krzek M, Undas A. High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals. Blood Coagul Fibrinolysis. 2013;24: 50-4.
28. Saku K, Ahmad M, Glas-Greenwalt P, Kashyap ML. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res. 1985;39: 1-8.
29. Undas A, Ariens RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31: e88-99.
30. Sakharov DV, Hekkenberg RT, Rijken DC. Acceleration of fibrinolysis by high-frequency ultrasound: The contribution of acoustic streaming and temperature rise. Thromb Res. 2000;100: 333-40.
31. Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost. 1997;78: 1063-8.
32. Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation. 1998;98: 1030-5.
33. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;39: 1366-73.
34. Pfaffenberger S, Decic-Kuhar B, Kollmann C, Kastl SP, Kaun C, Speidl WS, et al. Can a commercial diagnostic ultrasound device accelerate thrombolysis? an in vitro skull model. Stroke. 2005;36: 124-8.
35. Lindsey BD, Nicoletto HA, Bennett ER, Laskowitz DT, Smith SW. Simultaneous bilateral real-time 3-D transcranial ultrasound imaging at 1 MHz through poor acoustic windows. Ultrasound Med Biol. 2013;39(4): 721-34.
36. Wijnhoud AD, Franckena M, van der Lugt A, Koudstaal PJ, Dippel ED. Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density. Ultrasound Med Biol. 2008;34: 923-9.
37. Eden A. Transcranial Doppler ultrasonography and hyperostosis of the skull. Stroke. 1988;19: 1445-6.
38. Meairs S, Alonso A, Hennerici MG. Progress in sonothrombolysis for the treatment of stroke. Stroke. 2012;43: 1706-10.
39. Nedelmann M, Stolz E, Gerriets T, Baumgartner RW, Malferrari G, Seidel G, et al. Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke. 2009;40: 3238-44.